Bexsero wins major award
02 October 2014
Congratulations to Novartis Vaccines and Diagnostics Limited who have won a major award for their meningococcal group B (MenB) vaccine Bexsero®.
The vaccine beat seven other contenders for the Innovative Product Award at the 2014 UK Prix Galien Awards on 1 October. These awards, which like Meningitis Research Foundation (MRF) mark their 25th anniversary this year, recognise the contribution new medicines make to the lives of people with life threatening conditions and are held every other year.
Professor Michael Rawlins, Chair of the judging panel said: “Bexsero was the unanimous winner. Developing a vaccine has been extremely difficult. It is therefore fantastic that the pioneering research at Novartis has led to the use of genomic techniques in creating a broadly protective vaccine. ... we warmly applaud our new-found ability to address what was a big gap in childhood disease prevention.”
Christopher Head, MRF Chief Executive adds: “This is terrific news. We congratulate Novartis on this important recognition for Bexsero and trust it will help inspire the negotiations currently ongoing to implement the vaccine in the UK free of charge on the NHS.”
The awards were hosted in London by the former Shadow Minister for Health, the Rt. Hon. Sir Kevin Barron MP who is currently Chair of the All Party Pharmacy Group. He said: “The Prix Galien awards are commonly considered to be the Nobel Prize for pharmaceutical research. It’s a privilege to be here to applaud the labours of scientists, clinicians and healthcare leaders who continue to contribute enormously to the ongoing battle against human disease.... The sector’s continued commitment to improving health outcomes and curbing disease across the full gamut of chronic, long term and rare conditions is extraordinary. And set against a global backdrop of increased demand and diminishing resources, its achievements continue to astound.”
More on MenB
In-depth Q + A on the vaccine
Hi, I’m Sam and I’m MRF's PR Manager.
If you want to know more about this story call me on 0333 405 626251, out of office hours on 07875 498047 or email firstname.lastname@example.org